Inventor
Viola Groehn
Inventor
Dachsen, CH
Overview
Patents· 27 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes21%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C07DHeterocyclic compounds21%
C07BGeneral methods of organic chemistry13%
G01NInvestigating or analysing materials by determining their chemical or physical properties7%
A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for6%
C07CAcyclic or carbocyclic compounds3%
Y02PClimate change mitigation technologies in the production or processing of goods3%
C07KPeptides2%
A23VIndexing scheme relating to foods, foodstuffs or non-alcoholic beverages and lactic or propionic acid bacteria used in foodstuffs or food preparation1%
PatentTitleYear
11,066,408Crystalline binary sodium salts of 5-methyl-(6S)-tetrahydrofolic acid with organic bases202110,973,936None202110,961,246None202110,570,134Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid202010,377,756None201910,357,57618F-labelled folate/antifolate analogues201910,336,758Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid201910,322,195None201910,059,710Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid20189,993,481Methods and compositions for the treatment of metabolic disorders20189,878,044'Targeting aminoacid lipids'20189,796,666'Aminoacid lipids'20179,771,368'18F-labelled folates'20179,433,624'Methods and compositions for the treatment of metabolic disorders'20169,315,506'18F-labelled folates'20169,295,739'Folate conjugates of albumin-binding entities'20169,265,746'Method for cell-specific targeting'20168,344,139'Process for preparing crystalline polymorphic forms of (6R)-L-erythro-tetrahydrobiopterin dihydrochloride'20138,344,140'18F-labelled folates'20138,318,745'Crystalline forms of (6R)-L-erythro-tetrahydrobiopterin dihydrochloride'20128,067,416'Methods and compositions for the treatment of metabolic disorders'20117,816,525'Process for the preparation of optically pure tetrahydropterins and derivatives, and specifically of optically pure tetrahydrofolic acid and derivatives thereof, by stereospecific hydrogenation'20107,732,599'Process for preparing tetrahydrobiopterin and analogs of tetrahydrobiopterin'20107,727,987'Crystalline forms of (6R)-L-erythro-tetrahydrobiopterin dihydrochloride'20107,566,714'Methods and compositions for the treatment of metabolic disorders'20096,858,731'Process for the preparation of pure stereoisomers of tetrahydrofolic acid esters salts and tetrahydrofolic acid by fractionated crystallization of tetrahydrofolic acid esters salts'20056,344,468'Substituted isoindolones and their use as cyclic GMP modulators in medicaments'2002Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2002Based in Neuhausen, CH· patent location history
2005–2010Based in Neuhausen am Rheinfall, CH· patent location history
2009–2018Patents assigned to BIOMARIN PHARM INC (5)· patent assignee history
2009–2021Based in Dachsen, CH· patent location history
2010–2021Patents assigned to Merck & Cie (14)· patent assignee history
2010–2013Patents assigned to MERCK EPROVA AG (5)· patent assignee history
2011–2019Patents assigned to GROEHN VIOLA (9)· patent assignee history
2011–2019Patents assigned to MOSER RUDOLF (9)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| Merck & Cie | 14 | 2010–2021 |
| GROEHN VIOLAself | 9 | 2011–2019 |
| MOSER RUDOLF | 9 | 2011–2019 |
| BIOMARIN PHARM INC | 5 | 2009–2018 |
| MERCK EPROVA AG | 5 | 2010–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Dachsen, CH | 24 | 2009–2021 |
| Neuhausen am Rheinfall, CH | 2 | 2005–2010 |
| Neuhausen, CH | 1 | 2002 |